| Application no. and date | 04723608.8 (espacenet) (Federated) (European Patent Register), 20040326 | | Patent/reg. no. and date | DK/EP 1610787, 20080123 | | Publication date | 20060104 | | Priority no. and date | EP 03007104, 20030328 | | EP pub. no. and date |
EP 1610787 20060104 | | Effective date | | | Applicant/owner | AstraZeneca AB,
SE 151 85 Södertälje, SE | | Applicant ref. no. | P43817DK01 | | Inventor | WOLLIN, Stefan-Lutz, Lehrenweg 15/4
88709 Meersburg, DE,
WEIMAR, Christian, Helene und Maria Schiess-Str. 29
78467 Konstanz, DE,
BUNDSCHUH, Daniela, im rank 5
CH-8272 Ermatingen, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/46 (2006.01) , A61P 11/00 (2006.01) | | Title | Synergistisk kombination der omfatter roflumilast og et antikolinergt middel der er valgt blandt tiotropiumsalte til behandling af respiratoriske sygdomme | | Int. application no. | EP2004050376 | | Int. publication no. | WO2004084896 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
